Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 9;15(1):636.
doi: 10.1007/s12672-024-01228-1.

Asparaginase and isoaspartyl peptidase 1 RNA interference suppresses the growth of nasopharyngeal carcinoma cells

Affiliations

Asparaginase and isoaspartyl peptidase 1 RNA interference suppresses the growth of nasopharyngeal carcinoma cells

Bo Feng et al. Discov Oncol. .

Abstract

Nasopharyngeal carcinoma (NPC) is one of the common malignant tumors, and its pathogenesis has not been fully clarified. This study aims to explore the impact of RNA interference on the growth and invasion of NPC cells. Asparaginase and isoaspartyl peptidase 1 (ASRGL1)-short hairpin(sh) RNA expressing lentivirus was used to investigate the effect of ASRGL1 knockdown on NPC cells (C666-1 and SUN-1). The target shASRGL1 gene was determined by mRNA and protein expression in nasopharyngeal carcinoma cells; nasopharyngeal carcinoma cell proliferation viability, migration, invasion, apoptosis, ATP levels, and oxidative stress were examined. The results found that ASRGL1 was found to be highly expressed in NPC tissues and cell lines. shASRGL1 exhibited a high gene expression knockdown efficiency, downregulated the ASRGL1 protein expression in the nasopharyngeal carcinoma cells, suppressed proliferation viability of transfected nasopharyngeal carcinoma cells, inhibited their migration and invasion and ATP levels, promoted nasopharyngeal carcinoma cell apoptosis, ROS, and ferroptosis. shASRGL1 plays a role in protecting against NPC cell growth and invasion.

Keywords: Asparaginase and isoaspartyl peptidase 1; Nasopharyngeal carcinoma cell; RNA interference.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
ASRGL1 was highly expressed in Nasopharyngeal carcinoma tissues and cell lines. A The mRNA expression level of ASRGL1 in NPC patients was detected by RT-qPCR. Relative mRNA levels were compared in different groups, two-tailed, unpaired t-test, ***p < 0.001. B The protein expression level of ASRGL1 in NPC patients was detected by WB. Representative bands for the 5 cases are shown in the figure. Relative protein levels were compared in different groups, two-tailed, unpaired t-test, *p < 0.05. C The mRNA expression level of ASRGL1 in NPC cell lines was detected by RT-qPCR. Relative mRNA levels were compared in different groups. One-way ANOVA, **p < 0.01, ***p < 0.001. D The protein expression level of ASRGL1 in NPC cell lines was detected by WB. Relative protein levels were compared in different groups. One-way ANOVA, ***p < 0.001
Fig. 2
Fig. 2
The shASRGL1 suppressed C666-1 and SUN-1 cell proliferation viability and division. A ASRGL1 RNA interference genes were tested. The mRNA expression level of ASRGL1 was measured by RT-qPCR. Relative mRNA levels were compared in different groups, two-tailed, unpaired t-test, ***p < 0.001. B The protein expression level of ASRGL1 was measured by WB. Relative protein levels were compared in different groups, two-tailed, unpaired t-test, ***p < 0.001. C Cell proliferation was measured using a CCK-8 assay. The cell viability of the control group and the shASRGL1 group was compared by measuring the detection absorbance at 450 nm at different time points. Two-way ANOVA, ***p < 0.001, D The percentage of cell population in different phases of the cell cycle was quantified and compared between the control group and the shASRGL1 group. Two-tailed, unpaired t-test, *p < 0.05, *p < 0.01, ***p < 0.001
Fig. 3
Fig. 3
shASRGL1 inhibited C666-1 and SUN-1 cell migration and invasion. A Cell migration was assessed using the scratch test. The migration rate was compared between the shCtrl and shASRGL1 groups after 8 h of cell culture, two-tailed, unpaired t-test. The results showed a significant reduction in migration rate in the shASRGL1 group compared to the shCtrl group (***p < 0.001). B Cell invasion was performed using a transwell assay. Comparison of the migratory cells between shCtrl and shASRGL1 group. Two-tailed, unpaired t-test, *** p < 0.001
Fig. 4
Fig. 4
shASRGL1 promoted nasopharyngeal carcinoma cell apoptosis, ROS, and ferroptosis. A Apoptosis was assigned with Annexin V-FITC and PI double staining. Histograms of the shCtrl and shASRGL1 groups are shown. The percentage of early, late, and total apoptosis was quantified and compared between the shCtrl and shASRGL1 groups. Two-tailed, unpaired t-test, **p < 0.01, ***p < 0.001. B The protein expression level of Cleaved caspase3 and Cleaved caspase9 in NPC cell lines was detected by WB. Relative protein levels were compared between the shCtrl and shASRGL1 groups. Two-tailed, unpaired t-test, ***p < 0.001. C The level of ATP was quantified and compared between the shCtrl and shASRGL1 groups. Two-tailed, unpaired t-test, ***p < 0.001. D The protein expressions of ACSL4, FTH1 and GPX4 in cells were detected by WB. E ROS level was assigned with IF. Histograms of the shCtrl and shASRGL1 groups are shown

Similar articles

References

    1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. - PubMed
    1. Wei KR, et al. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):90. - PMC - PubMed
    1. Lin J-C. Adjuvant chemotherapy in advanced nasopharyngeal carcinoma based on plasma EBV load. J Radiat Oncol. 2012;1:117–27.
    1. Hu JY, et al. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: initial results. Cancer. 2018;124(11):2427–37. - PMC - PubMed
    1. Chen Y, et al. Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China. Cancer. 2013;119(12):2230–8. - PubMed

LinkOut - more resources